KL
Kalaris Therapeutics Inc
KLRS · NASDAQ
$3.16 -0.63% (-$0.02)
1M -21.95%
Market Cap $69.0M
P/E Ratio -
Div. Yield -
ROE 71.71%
Bulios Fair Price
$2.14
32.3% downside
Trenutna cena
$3.16
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica KLRS trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
0/9Valuation
100 /100
Cheap P/B 1.20x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
0 /100
Poor ROIC 52.40%
Asset turnover 0.00x
ROE 71.71%
Debt
100 /100
Low Debt/Equity 0.02x
Current ratio 10.98x
Int. coverage N/A
Stability
29 /100
Unstable Beta 0.21x
Profitable years 0
EPS volatility 32.99%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o KLRS
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Andrew Oxtoby
Employees
20
Headquarters
Berkeley Heights
Prihajajoči dogodki
11 NOV.
Earnings
Upcoming earnings report